A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene
B Düsterberg, H Ellman, U Müller… - Gynecological …, 1996 - Taylor & Francis
This long-term, open-label, multicenter study investigated the clinical efficacy and tolerability
of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μ ggestodene …
of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μ ggestodene …
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: Gestodene/ethinylestradiol and norgestimate/ethinylestradiol
P Affinito, M Monterubbianesi, M Primizia… - Gynecological …, 1993 - Taylor & Francis
Two monophasic oral contraceptives containing gestodene (GTD, 15 μg) and
ethinylestradiol (EE, 30 μg) or norgestimate (NGS, 250 μg) and EE (35 μg) were compared …
ethinylestradiol (EE, 30 μg) or norgestimate (NGS, 250 μg) and EE (35 μg) were compared …
Clinical acceptability of monophasic gestodene
B Düsterberg, K Brill - American journal of obstetrics and gynecology, 1990 - Elsevier
The monophasic low-dose contraceptive containing 30 μg of ethinyl estradiol and 75 μg of
gestodene has been tested in numerous clinical studies to determine contraceptive …
gestodene has been tested in numerous clinical studies to determine contraceptive …
Clinical experience with a low-dose oral contraceptive containing gestodene.
B Düsterberg, K Brill - … in Contraception: the Official Journal of the …, 1990 - europepmc.org
The monophasic combination preparation containing 30 micrograms ethinyl estradiol and
75 micrograms gestodene was tested for contraceptive reliability, cycle control and …
75 micrograms gestodene was tested for contraceptive reliability, cycle control and …
Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene
M Renier, P Buytaert - Contraception, 1991 - Elsevier
In a large and open prospective multicenter trial of 12,250 cycles from 2,378 women,
contraceptive efficacy, clinical tolerance and acceptability of a new monophasic …
contraceptive efficacy, clinical tolerance and acceptability of a new monophasic …
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 …
J Endrikat, U Müller, B Düsterberg - Contraception, 1997 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …
Dose finding in a low-dose 21-day combined oral contraceptive containing gestodene
F Lüdicke, H Sullivan, J Spona, M Elstein - Contraception, 2001 - Elsevier
An open label, non-comparative study was carried out in 22 women over a total of five
cycles. After an untreated cycle, oral administration of 20 μg ethinyl estradiol (EE) with 50 μg …
cycles. After an untreated cycle, oral administration of 20 μg ethinyl estradiol (EE) with 50 μg …
Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol
Latin American Oral Contraceptive Study Group - Contraception, 1994 - Elsevier
The efficacy, cycle control, subjective complaints, and safety of monophasic preparations of
the oral contraceptives containing gestodene 75 mcg plus ethinyl estradiol 30 mcg versus …
the oral contraceptives containing gestodene 75 mcg plus ethinyl estradiol 30 mcg versus …
Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents
K Brill, J Schnitker, M Albring - Advances in contraception, 1994 - Springer
This clinical investigation of a low-dose, monophasic gestodene-containing oral
contraceptive (75 μg gestodene/30 μg ethinylestradiol), investigated contraceptive efficacy …
contraceptive (75 μg gestodene/30 μg ethinylestradiol), investigated contraceptive efficacy …
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol …
J Endrikat, MA Jaques, M Mayerhofer, C Pelissier… - Contraception, 1995 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a …
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a …